What is Standard Chemical & Pharmaceutical Co Days Payable?
Standard Chemical & Pharmaceutical CoTPE:1720 95 Days Payable is 33.21 as of Dec. 2025, which is 18% above its 10-year median of 28.23. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.94 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 927 Drug Manufacturers companies, Standard Chemical & Pharmaceutical Co ranks worse than 89.75% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Standard Chemical & Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Days Payable falls into.
Standard Chemical & Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Days Payable of 33.21 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. This is 18% above median its historical median of 28.23. Over the past decade, Standard Chemical & Pharmaceutical Co's Days Payable has ranged from 21.24 to 38.35. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #832 out of 927 companies in the Drug Manufacturers industry, placing it in the top 89.8%.
Is Standard Chemical & Pharmaceutical Co's Days Payable too high?
Standard Chemical & Pharmaceutical Co's current Days Payable of 33.21 is 18% above median its 10-year median of 28.23. Over the past 10 years, this metric has ranged from a low of 21.24 to a high of 38.35. The Drug Manufacturers industry median Days Payable is 90.38. Standard Chemical & Pharmaceutical Co's value of 33.21 is 63.3% below this industry median. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #832 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #832 out of 927 companies for Days Payable. This places Standard Chemical & Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 90.38. Standard Chemical & Pharmaceutical Co's value of 33.21 is 63.3% below this benchmark. Historically, Standard Chemical & Pharmaceutical Co's own Days Payable has ranged from 21.24 to 38.35 over the past decade. While the company's 10-year median is 28.23 vs. the industry median of 90.38, Standard Chemical & Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Standard Chemical & Pharmaceutical Co's current Days Payable of 33.21 is 63.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Standard Chemical & Pharmaceutical Co's current Days Payable is 33.21, which is 18% above median its own 10-year median of 28.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.94, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Days Payable is 33.21, which is 18% above median its 10-year median of 28.23 and 63.3% below the Drug Manufacturers industry median of 90.38. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Days Payable is 33.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.94.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TPE:1720:
Days Payable: 33.21 (18% above median its 10-year median of 28.23)
GF Value™: NT$70.94 vs. price of NT$63.90 (9.9% below fair value)
Industry Position: 63.3% below the Drug Manufacturers median (#832 of 927)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Business Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score
Get the complete analysis for TPE:1720
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
